Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective and Retrospective Breast Cancer Database

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02884284
Recruitment Status : Recruiting
First Posted : August 31, 2016
Last Update Posted : August 31, 2016
Sponsor:
Information provided by (Responsible Party):
Institut Claudius Regaud

Brief Summary:

In order to accelerate border crossing between basic research and clinical research in breast cancer, it is necessary to easily use clinical and biological data. That is the reason why it is very important to create a clinical, biological and pathologic beast cancer database, mainly prospective but also retrospective. All data are from patients treated in Toulouse Centre.

The scientific community will easily have access to clinical and biological informations through a centralized, structured database , leading to optimize patients with breast cancer treatment.


Condition or disease Intervention/treatment
Breast Cancer Other: clinical biological database collection

Layout table for study information
Study Type : Observational
Estimated Enrollment : 10000 participants
Time Perspective: Prospective
Official Title: Creation of a Prospective and Retrospective Breast Cancer Database
Study Start Date : February 2015
Estimated Primary Completion Date : January 2025
Estimated Study Completion Date : December 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer




Primary Outcome Measures :
  1. Database of patients with breast cancer [ Time Frame: 10 years ]

Biospecimen Retention:   Samples With DNA
blood samples and tumor samples of patients treated for breast cancer


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Female patient with breast cancer of any stage
Criteria

Inclusion Criteria:

  • Female patient
  • Histologically confirmed breast cancer of any stage
  • Affiliated to a social security system in france
  • Who signed the informed consent

Exclusion Criteria:

  • Any psychiatric or medical condition that would make the patient unable to give a signed informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02884284


Contacts
Layout table for location contacts
Contact: Florence DALENC, MD 5 31 15 51 22 ext 33 dalenc.florence@iuct-oncopole.fr

Locations
Layout table for location information
France
Institut claudius regaud IUCT ONCOPOLE Recruiting
Toulouse, France, 31059
Contact: Florence DALENC, MD    5 31 15 51 22 ext 33    dalenc.florence@iuct-oncopole.fr   
Sponsors and Collaborators
Institut Claudius Regaud
Investigators
Layout table for investigator information
Principal Investigator: Florence DALENC, MD Institut claudius regaud Toulouse ONCOPOLE

Layout table for additonal information
Responsible Party: Institut Claudius Regaud
ClinicalTrials.gov Identifier: NCT02884284     History of Changes
Other Study ID Numbers: 15HLSEIN01
First Posted: August 31, 2016    Key Record Dates
Last Update Posted: August 31, 2016
Last Verified: August 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Institut Claudius Regaud:
breast cancer
database

Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases